TipRanks
Go Ultimate55% OFF

Orchestra BioMed Holdings (OBIO) Cash flow

Orchestra BioMed Holdings Cash Flow

OBIO's free cash flow for Q2 2026 was $-19.59M. For the 2026 fiscal year, OBIO's free cash flow was decreased by $-254.00K and operating cash flow was $-19.33M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Mar 25Dec 23Dec 22Dec 21
$ -48.96M$ -50.56M$ -46.13M$ -29.29M$ -19.43M
$ -26.94M$ 13.09M$ 10.69M$ -64.12M$ 13.02M
$ 88.33M$ 29.17M$ 46.22M$ 103.26M$ -3.99M
$ 34.69M$ 22.26M$ 30.56M$ 19.78M$ 9.94M
$ -49.45M$ -50.85M$ -46.20M$ -29.88M$ -19.70M

Currency in USD

Orchestra BioMed Holdings Cash Flow

-100M-50M050M100M150M202020212022202320242025OperatingInvestingFinancing